RSS

Category Archives: Pharmaceutical

Human Embryonic Stem Cells Market – Global Industry Analysis, Trends and Forecast, 2013 – 2019

Human Embryonic Stem Cells Market

Human embryonic stem cells (hESCs) are derived from blastocyst and are capable of differentiating into number of cell types that make up the human body. hESCs can replicate indefinitely and produce non-regenerative tissues such as neural and myocardial cells. These abilities of human embryonic stems cells allow them to be used as a tool in regenerative medicine and research. Because of their capacity for self-renewal, they can be used in treating a number of blood and genetic disorders related to the immune system, cancers, and disorders. Human embryonic stem cells are also used in investigational studies of early human development, genetic diseases and toxicology testing.

Browse PDF Report @:Human Embryonic Stem Cells Market – Global Industry Analysis, Trends and Forecast, 2013 – 2019

The global human embryonic stem cells market is categorized on the basis of following applications:

  • Toxicology testing
  • Tissue engineering
  • Regenerative medicines
  • Stem cell biology research
Currently, North America dominates the global human embryonic stem cells market and is followed by Europe due to high prevalence of cardiac and malignant diseases. Developing nations of Asia, Middle East and Latin America are also expected to show rapid growth in this market due to increasing medical tourism and the flourishing contract research outsourcing market in these regions.

Browse Report @:http://www.transparencymarketresearch.com/human-embryonic-stem-cells.html

The major factors driving the demand for human embryonic stem cells include extensive therapeutic research activities in this field, rapid growth in medical tourism, emerging stem cell banking services. Additionally, increase in incidences of cardiac and neurological disorders around the world owing to the stressful lifestyle and receipt of funds from various organizations will also propel the growth of this market.
Some of the key players contributing to the human embryonic stem cells market include Australian Stem Cell Centre, BD Biosciences, Cellartis AB, Millipore Corporation, Geron Corporation, Invitrogen Corporation, Viacyte, Inc., R&D Systems, Inc., SA Biosciences Corporation, Tataa Biocenter, Thermo Scientific and Vitrolife AB.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Browse Upcoming Reports @:http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact us:-

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Market Research Firm Blog @: http://market-research-firm.blogspot.com/

 

 
Leave a comment

Posted by on September 19, 2013 in Pharmaceutical

 

Tags:

Market Research Report:Adjuvants Market – Global Industry Analysis,Trends and Forecast (2012-2018)

Adjuvants Market

Adjuvant oncology treatment comprises of a class of cancer therapeutics which is followed after primary cancer treatment, to minimize the risk of reoccurrence of cancer. The major forms of adjuvant therapy are radiation therapy, chemotherapy, hormone therapy, biological therapy, and targeted therapy. Before deciding the adjuvant therapy to be used, statistical evidence is used by oncologists for the assessment of risk of disease relapse.

Increase in prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer and growth in preference for the future prevention of cancer are some of the major drivers of this market. Growth in research initiatives in increasing the scope of the diseases which could be treated with adjuvant therapy serve as the prime opportunity for the future growth of this market.

The major aim of giving adjuvant therapy to cancer patients is to increase the chance of overall survival of such patient. Since the rationale behind adjuvant therapy is elimination of future risk, the accepted rule is that the patients were already cured via primary surgical treatment. Thus, such therapies given after an oncological surgery for different types of cancers such as that of lung, breast, colon, prostate, and various forms of gynecological cancers. Adjuvant therapy is often given after oncology surgery the treatment procedure of illnesses such as colon cancer, pancreatic cancer, gynecological cancer, breast cancer, lung cancer, and prostate cancer. However, some forms of cancer such as renal carcinoma and some types of brain cancer have failed to benefit from such a therapy.

The overall market for oncology adjuvants is classified on the basis of applications of adjuvants such as chemotherapy, radiotherapy, immunotherapy and others. On the basis of diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer.

Some of the market players in this industry include pharmaceutical manufacturers such as Amgen, Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, Pfizer, Inc. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact us:-

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Market Research Firm Blog @: http://market-research-firm.blogspot.com/

 
Leave a comment

Posted by on August 27, 2013 in Pharmaceutical

 

Tags:

Market Research Report:Psoriatic Arthritis Pharmacotherapy Market – Trends, and Forecast 2012 – 2018

 Psoriatic Arthritis Pharmacotherapy Market

Psoriatic Arthritis is a type of rheumatoid arthritis which mainly affects fingers and toes followed by psoriasis. Moreover, a condition in which person has both psoriasis and arthritis is identified to have suffered from psoriatic arthritis. Major symptom for psoriatic arthritis is associated with inflammation of the skin and joints. About 11% of patients who has psoriatic also develop inflammation of their joints in a time frame ranging from 6 months to 1 year or sometimes even more, depending upon the personality of the patient.

The global psoriatic arthritis pharmacotherapy market has experienced strong growth rate and is forecasted to experience continued growth in the future years due to increased use of biologics drugs mainly tumor necrosis factor inhibitor (TNF). There exist five different types of psoriatic arthritis which includes different joints and spinal column. Also, there are three main category of drugs such as DMARDs (disease modifying anti-rheumatic drugs), biologics and NSAIDs.

Some of the major players analyzed in this report are Pfizer, Amgen, Merck, Roche, Johnson & Johnson, Abbott and Novartis.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact us:-

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Market Research Firm Blog @: http://market-research-firm.blogspot.com/

 
Leave a comment

Posted by on August 26, 2013 in Pharmaceutical

 

Tags:

Market Research Report:Occult Blood Testing Market – Global Industry Analysis, Trends, and Forecast 2012 – 2018

 Occult Blood Testing Market

Occult blood testing is carried out to test for the presence of microscopic or invisible blood cells in the stool. It is a type of colorectal cancer screening test. Occult blood is the sign of a problem in the digestive system, which can be a polyp, growth, or a cancer in the rectum or colon. Once microscopic blood is detected, proper diagnosis can take place. Occult blood can also be the result of ulcerative colitis, Crohn’s disease, diverticular disease (caused by outpouching of the colon wall), and abnormalities of the blood vessel in the large intestine, etc. The world’s occult testing technological market is expected to see a gradual increase during the period from 2012 to 2018.

Some of the drivers of this market are an increase in the number of cases of gastrointestinal bleeding, increasing alcoholism leading to more cases of occult blood, and technological advancement in the field of medicine and surgery.

The market for occult blood testing technologies can be categorized on the basis of products into DNA probes, biochips/microarrays, immunoassays, IT, chromosome analysis, monoclonal antibodies, and other technologies. Geographically, the market can be divided into the European Union which constitutes the largest market, followed by Asia-Pacific and North America in terms of market share.

Some of the factors restraining the growth of this market are lack of proper information regarding testing technologies, lack of self evaluation capabilities among the population of developing countries, and low disposable incomes in such countries. The developing education and healthcare infrastructure along with a rise in economic conditions are some of the opportunities of the occult blood testing market.

Some of the major players in this market are Abbott, Wako, ID Biomedical, Hologic, Lonza, Exact Sciences, Fujirebio, Becton Dickinson, Ipsogen, Eiken Chemicals, Solvay, Life Technology, DiaSorin, Enzo Biochem, Thermo Fisher, Wallac, Diagnocure, GenCure, Nanogen Elitech and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact us:-

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Market Research Firm Blog @: http://market-research-firm.blogspot.com/

 
Leave a comment

Posted by on August 26, 2013 in Pharmaceutical

 

Tags:

Latest Report:Immunoglobulin Products Market – Global Industry Analysis, Growth, Trends and Forecast, 2013 – 2019

 

Immunoglobulin Products Market

Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. These are made up of basic structural unit’s namely heavy chains and light chains.

In mammals five different types of antibodies (IgA, IgD, IgE, IgG and IgM) are present which perform different role in response to the type of foreign antibody encountered. Occurrences of situations where people are born with low or no level of immunoglobulin, or with an immune system that does not function properly are very common. In such condition fighting with germs and other infections become extremely difficult. Therefore, immunoglobulin therapy plays an important role for compensating the insufficient quantity of immunoglobulin in the body.

Browse PDF Report @:Immunoglobulin Products Market 

The World Health Organization (WHO) has identified more than 100 immunodeficiencies, ranging from extremely rare deficiency to common deficiency of IgA. IgA accounts for 75% of the total immunoglobulin produced in the body. IgA is produced in mucosal lining and between three to five grams are secreted in to the intestinal lining each day. Therefore, immunoglobulins are commercially produced for treating immunodeficient patients. There are many commercially available immunoglobulin’s namely Privigen, Gammagard S/D, Gamunex-C, Gammaplex, Octagam 5% and others.

Immunoglobulin products market is expected to grow due to rise in aging population as production of antibody decreases that leads to weaker immune system. Thus, the continuous rise in aging population would lead to rise in number of immunodeficient patients. Hence, the immunoglobulin market is expected to grow at a steady growth and would not be affected due to weak product pipeline with few innovations.

Despite the challenges, immunoglobulin products market is witnessing significant mergers and acquisitions for the development of new and innovative products. In addition, market is also expected to grow with increase in number of patients and increasing awareness about the diseases. Some of the market players in this industry are Baxter International Inc., CSL Behring LLC, Grifols S.A., Octapharma AG and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact us:-

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Market Research Firm Blog @: http://market-research-firm.blogspot.com/

 
Leave a comment

Posted by on August 16, 2013 in Pharmaceutical

 

Tags:

New Report:Anti-Infectives Market – Global Industry Analysis,Trends and Forecast, 2012 – 2018

Anti-Infectives Market

Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host organism by means of its replication or releasing variety of toxins in the host. Such infection causing micro-organisms include viruses, bacteria, fungi, viroids and macro parasites. Infections thus caused can be classified depending on the type of organism causing infection and the symptoms and medical signs shown by host.

The global market for anti-infectives is classified by product type as antifungal, antiviral and antibacterial depending on the type of organism they fight. Geographically, North America is the most dominating region in the anti-infectives market and is followed by Europe. The emerging economies of Asia-Pacific regions are also showing growth potential in the global anti-infectives market. India forecasts high potential for growth in demand for anti-infectives due to existence of large patient pool, the government initiatives of undertaking various control programs and private partnership projects and rising cost containment initiatives by drug manufacturers.

Some of the major driving factors for the anti-infectives market include increase in patient population, large number of vaccines gaining approvals and newer drug introductions. The growing resistance of infection causing organisms to the existing drug therapies could pose a major challenge to the anti-infectives market. Furthermore, high price of drugs, dicey reimbursement policies and competition between generic manufacturers may hold back the growth of this market. The anti-infectives market is highly fragmented with a large number of domestic and international players. Developmental focus of anti-infective agents has shifted to antiviral agents due to requirement of longer treatment regimens in large number of patient population with chronic indications as compared to antifungal and antibacterial agents requiring shorter treatments.

Some of the key players contributing to the growth of this market include Abbott Laboratories Limited, Cipla Ltd., Claris Life Sciences Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Novartis AG, Panacea Biotech Ltd., Pfizer Ltd., Ranbaxy Laboratories Ltd. and Sun Pharmaceutical Industries Ltd.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact us:-

State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Business Research Firm Blog @: http://market-research-firm.blogspot.com/

 
Leave a comment

Posted by on August 14, 2013 in Pharmaceutical

 

Tags:

Vaccine Production Market – Global Industry Analysis, Size, Share,Growth And Forecasts 2012 – 2018

Vaccine Production Market

High growth rate in emerging markets, technological advancements, strong support from governments and other active associations like WHO and GAVI, and increased investment in research and development are all leading to the overall growth of the vaccine production market. The vaccine production market is expected to exhibit improved performance in the coming years due to the successful launch of new vaccines.

Vaccines for different illnesses are among the top revenue earners in the pharmaceutical industry. Research and development in this field is leading to the production of improved and effective vaccines for various illnesses. Substantial revenue growth in the vaccine production market in recent years shows the increasing enormity of this industry.

Vaccine Production Market Segmentation

Vaccine production market is segmented as follows:

Adult Vaccine Production

  • Hepatitis B
  • Malaria
  • Yellow Fever
  • Typhoid
  • Rabies
  • HIV
  • Cancer
  • Influenza
  • West Nile
  • Japanese Encephalitis
Pediatric Vaccine Production

  • Pneumococcal
  • Rotavirus
  • DTP
  • Polio
  • Varicella
  • Meningococcal
  • Measles, Mumps and Rubella
  • Tuberculosis
Both, adult and pediatric segments have a constant growth momentum. The major players have been formulating strategies to enlarge their global presence in the vaccine production market.

This report analyzes the industry growth rate¸ current trends, and industry structure. It includes the study of current developments in the vaccine production market, Porter’s five force analysis, and detailed profiles of the top industry players. This report provides a detailed review of macro and micro factors significant for the existing market players and new entrants along with value chain analysis.

The major geographies studied under this research are North America, Europe, Asia-Pacific, and the Rest of the World.

The key players dominating this market are GlaxoSmithKline Biopharmaceuticals, Sanofi Aventis, Merck KgaA, Pfizer-Pfizer CenterSource, Novartis AG, Baxter International, Teva, Crucell (Johnson & Johnson), Intercell, CSL Biotherapies, MassBioLogics, MedImmune/ Astra Zeneca, and others.

Vaccine production is also done on contractual basis. Major players involved in manufacturing vaccines on contractual basis are Boehringer Ingelheim, Fujifilm Diosynth Biotechnology, Catalent Pharma Solutions, Patheon, Cambrex, Lonza, IDT Biologika, Charles River Biopharmaceutical Services (BPS), and others.

About us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact us:-

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com

Business Research Firm Blog @: http://market-research-firm.blogspot.com/

 
Leave a comment

Posted by on August 13, 2013 in Pharmaceutical

 

Tags: